Goldenwell Biotech, Inc.
GWLL · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $53 | $46 | $214 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $224 | $228 | $222 | $412 |
| Property Plant & Equip (Net) | $0 | $0 | $26 | $49 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $26 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $224 | $228 | $248 | $461 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $111 |
| Short-Term Debt | $0 | $0 | $25 | $48 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $1 | $1 | $0 |
| Other Curr. Liab. | $0 | $1 | $0 | $0 |
| Total Curr. Liab. | $2 | $1 | $27 | $159 |
| LT Debt | $96 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $174 | $142 | $20 | -$0 |
| Total NC Liab. | $270 | $142 | $20 | -$0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $25 | $48 |
| Total Liabilities | $271 | $143 | $47 | $159 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $10 | $10 | $10 | $10 |
| Retained Earnings | -$1,360 | -$1,228 | -$1,111 | -$126 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $1,303 | $1,303 | $1,303 | $418 |
| Total Equity | -$47 | $85 | $202 | $302 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $224 | $228 | $248 | $461 |
| Net Debt | $46 | -$53 | -$21 | -$166 |